돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 404535생성일: 2026년 10월 24일

Hydrochloric Acid → Erlotinib Hydrochloride

https://huagongshe.com/ko/reaction/404535

반응식

참여 물질

역할이름HCID투입량
반응물Hydrochloric AcidHCID 313—
반응물ErlotinibHCID 176870—
용매DichloromethaneHCID 6344—
생성물Erlotinib HydrochlorideHCID 17687190.8%

반응 단계

Into a 3 Lt. four necked round-bottomed flask provided with a mechanical stirrer, thermometer socket, reflux condenser etc., are charged 2400 mL of methylene chloride, followed by 120 g of Erlotinib base (Prepared according to the process given in Example-(1) of PCT International Publication No. WO 2007/060691) under stirring. The reaction mass is slightly warmed up to 37±1° C., so that the Erlotinib base completely dissolves in the solvent. Then carbon treatment is given and the filtrate is transferred to 5 Lt. three necked round bottomed flask, provided with a mechanical stirrer and other accessories. To this filtrate, isopronolic HCl (HCl content as 100% is 13.90 g) is added in one lot at 30-35° C. and then the reaction mass is refluxed for about 3 hrs. Afterwards, the reaction mass is cooled to room temperature and filtered. The product is washed with methylene chloride and the wet cake is dried to get 119 g of Erlotinib hydrochloride as a white crystalline powder.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08748602B2
출처 데이터셋uspto-grants-2014_06
ORD IDord-eba6c46d3da34e9cab8468e49ba6e5f0
출처 메모uspto-grants-2014_06